Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model
/in International Publications, Malignant Melanoma, Newcastle Disease VirusRadiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response
/in Dendritic Cells, Hypernephroma, International Publications, Malignant MelanomaEfficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route
/in Dendritic Cells, International Publications, Malignant MelanomaVaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised „proof-of-principle“ phase II study
/in Dendritic Cells, International Publications, Malignant MelanomaLong overall survival after dendritic cell vaccination in metastatic uveal melanoma patients
/in Dendritic Cells, International Publications, Malignant MelanomaMelanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells
/in Dendritic Cells, International Publications, Malignant MelanomaDasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma
/in Dendritic Cells, International Publications, Malignant MelanomaLong-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates
/in Dendritic Cells, International Publications, Malignant MelanomaNovel dendritic cell-based vaccination in late stage melanoma
/in Dendritic Cells, International Publications, Malignant MelanomaIMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de